Cardiovascular Drugs
1,020 FDA-approved drugs
TheraRadar tracks 1,020 FDA-approved cardiovascular drugs from 289 companies across 53 drug classes, led by B BRAUN, with 1,476 active clinical trials in the pipeline. Explore recent approvals, top companies, active trials by indication, and drug classes for Cardiovascular.
Cardiovascular Approvals by Year
14
'15
17
'16
14
'17
7
'18
15
'19
12
'20
18
'21
17
'22
9
'23
14
'24
19
'25
'26
Recent Cardiovascular Drug Approvals
MYQORZO
AFICAMTEN
adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacit...
2025-12-19
CYTOKINETICS
CARDAMYST
ETRIPAMIL
the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to si...
2025-12-12
MILESTONE PHARMS USA
JAVADIN
CLONIDINE HYDROCHLORIDE
hypertension in adult patients, to lower blood pressure...
2025-10-23
AZURITY
LASIX ONYU
FUROSEMIDE
edema in adult patients with chronic heart failure...
2025-10-07
SQ INNOVATION
ENBUMYST
BUMETANIDE
edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic s...
2025-09-12
CORSTASIS THERAP
CANGRELOR
CANGRELOR
Cangrelor for injection is indicated as an adjunct to percutaneous coronary intervention (PCI) to re...
2025-08-11
GLAND
SDAMLO
AMLODIPINE BESYLATE
hypertension, to lower blood pressure in adults and pediatric patients 6 years of age and older...
2025-07-24
BRILLIAN PHARMA
VOSTALLY
RAMIPRIL
hypertension, to lower blood pressure...
2025-07-23
ROSEMONT PHARMS
DEHYDRATED ALCOHOL
DEHYDRATED ALCOHOL
1 INDICATIONS & USAGE Dehydrated alcohol injection is indicated to induce controlled cardiac septal ...
2025-06-23
XGEN PHARMS
WIDAPLIK
AMLODIPINE BESYLATE
hypertension in adult patients, to lower blood pressure...
2025-06-05
AZURITY
ANGIOTENSIN ll ACETATE
ANGIOTENSIN II ACETATE
2025-06-03
GLAND
YUTREPIA
TREPROSTINIL SODIUM
pulmonary arterial hypertension (PAH; WHO Group 1) to improve exercise ability...
2025-05-23
LIQUIDIA TECH
ELIQUIS SPRINKLE
APIXABAN
DVT...
2025-04-17
Bristol-Myers Squibb
THROMBIN
HEMICLOR
CHLORTHALIDONE
hypertension in adults, to lower blood pressure...
2025-03-17
PRM PHARMA
ARBLI
LOSARTAN POTASSIUM
hypertension in adults and pediatric patients 6 years of age and older, to lower blood pressure...
2025-03-13
SCIENTURE
RIVAROXABAN
RIVAROXABAN
Rivaroxaban tablet is a factor Xa inhibitor indicated: to reduce the risk of major cardiovascular ev...
2025-03-03
MACLEODS PHARMS LTD
THROMBIN
DILTIAZEM HYDROCHLORIDE IN 0.72% SODIUM CHLORIDE
DILTIAZEM HYDROCHLORIDE
hypertension...
2025-02-21
HQ SPCLT PHARMA
INZIRQO
HYDROCHLOROTHIAZIDE
hypertension in adult and pediatric patients, to lower blood pressure...
2025-01-28
NOVITIUM PHARMA
AZILSARTAN MEDOXOMIL AND CHLORTHALIDONE
AZILSARTAN KAMEDOXOMIL
hypertension, to lower blood pressure...
2025-01-21
ALKEM LABS LTD
IOBENGUANE I-123
IOBENGUANE SULFATE I-123
2024-12-09
BWXT MEDCL
Showing the 20 most recent of 1,020 cardiovascular drugs. View all 1,020 →
Top Cardiovascular Companies
Cardiovascular Active Trials by Indication
1,476 active trials — the forward pipeline, not just approvals.
Stroke 374 Hypertension 331 Heart Failure 280 Coronary Artery Disease 167 Atrial Fibrillation 125 Myocardial Infarction 102 Thrombosis 49 Arrhythmia 25
All competitive landscapes → Cardiovascular Drug Classes
Thiazide Diuretic 26
Angiotensin 2 Receptor Blocker 11
Nitrate Vasodilator 10
Loop Diuretic 8
Thiazide-like Diuretic 8
Dihydropyridine Calcium Channel Blocker 7
Endothelin Receptor Antagonist 6
alpha-Adrenergic Agonist 6
Anti-coagulant 5
Prostacycline Vasodilator 5
Cardiovascular at a Glance
- Total Drugs
- 1020
- Companies
- 289
- Drug Classes
- 53
- Active Trials
- 1,476
- Latest Approval
- 2025-12-19